Defined anaerobic growth medium for studying Candida albicans basic biology and resistance to eight antifungal drugs.
about
Candida albicans and Pseudomonas aeruginosa Interaction, with Focus on the Role of EicosanoidsThe airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic managementInterspecies Interactions between Clostridium difficile and Candida albicansDiversity of the microeukaryotic community in sulfide-rich Zodletone Spring (Oklahoma)Self-regulation of Candida albicans population size during GI colonization.Synergistic regulation of hyphal elongation by hypoxia, CO(2), and nutrient conditions controls the virulence of Candida albicansGenome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicansFarnesol concentrations required to block germ tube formation in Candida albicans in the presence and absence of serum.Interspecies competition triggers virulence and mutability in Candida albicans-Pseudomonas aeruginosa mixed biofilms.Molecular analysis of meso- and thermophilic microbiota associated with anaerobic biowaste degradationA glucose sensor in Candida albicansRegulatory networks controlling nitrogen sensing and uptake in Candida albicans.Antimicrobial effects of liquid anesthetic isoflurane on Candida albicans.An assessment of growth media enrichment on lipid metabolome and the concurrent phenotypic properties of Candida albicansIn vivo and in vitro anaerobic mating in Candida albicans.Fungal biofilm resistance.Comparison of E,E-Farnesol Secretion and the Clinical Characteristics of Candida albicans Bloodstream Isolates from Different Multilocus Sequence Typing Clades.Function and Regulation of Cph2 in Candida albicans.Talking to themselves: autoregulation and quorum sensing in fungi.Quorum sensing in dimorphic fungi: farnesol and beyondComparison of sterol import under aerobic and anaerobic conditions in three fungal species, Candida albicans, Candida glabrata, and Saccharomyces cerevisiae.Farnesol and dodecanol effects on the Candida albicans Ras1-cAMP signalling pathway and the regulation of morphogenesisCellular interactions of farnesol, a quorum-sensing molecule produced by Candida albicans.Quorum sensing in fungi--a review.Microbial chemical signaling: a current perspective.Miconazole, a pharmacological barrier to skin fungal infections.Effect of alcohols on filamentation, growth, viability and biofilm development in Candida albicansFarnesol signalling in Candida albicans - more than just communication.Biotin Auxotrophy and Biotin Enhanced Germ Tube Formation in Candida albicansRegulation of aromatic alcohol production in Candida albicans.Effects of chitosan on Candida albicans: conditions for its antifungal activity.Activity and toxicity of farnesol towards Candida albicans are dependent on growth conditions.Morphogenesis control in Candida albicans and Candida dubliniensis through signaling molecules produced by planktonic and biofilm cells.Candida albicans alters the bacterial microbiome of early in vitro oral biofilms.A farnesoic acid-responsive transcription factor, Hot1, regulates yeast-hypha morphogenesis in Candida albicans.Mechanisms involved in the inhibition of glycolysis by cyanide and antimycin A in Candida albicans and its reversal by hydrogen peroxide. A common feature in Candida species.Candida Species Biofilms' Antifungal Resistance.Increase of the transdermal penetration of testosterone by miconazole nitrate.Deciphering fungal dimorphism: Farnesol's unanswered questions.Genetic and phenotypic evaluation of Candida albicans strains isolated from subgingival biofilm of diabetic patients with chronic periodontitis.
P2860
Q26767229-26C93FE8-D795-4FF3-B5BF-F668C35B46EDQ28730299-A3E4C20D-7321-4B1A-B0AD-8D841ACB8396Q28821706-712EDEC7-8E06-4932-89AB-A6D2254B7E94Q33224568-7801A81B-9B4E-4BA6-A5E5-828637612DC5Q33309459-6DB12B2A-3E24-4849-98CC-D255EB55B0A6Q33727070-854E1FB0-68CC-43DA-9F00-A0630760D0D2Q33836717-2D5A87BC-4A37-4FDB-B1D8-F2DB02008928Q33913164-A5605B37-1FBD-440F-B9CF-62D0945D0859Q34284493-BC44A05C-1A82-440D-A490-8F7218411F7BQ34315332-8D4CF44A-70BE-4777-8BB8-97F604D044A7Q35075215-2B781DB7-CF24-44A2-BB05-04B032FC6946Q35126060-E4A85128-3862-4FB5-B178-6633E2C50E94Q35172005-F85BC88A-3B75-4E73-90B9-7B8F5C81650DQ35448907-C8242AA8-67D8-43C4-8CEF-6FE17BE45FD2Q35690201-F8C5746E-7E5F-4082-959A-72304BFD5BFBQ35821475-233BCD6D-46BF-403F-8E64-27DC86158149Q35915352-D4E718B4-080B-46E0-BDD2-7E592865FEC9Q36208858-D6D605F2-E936-43A2-8581-1FD4DD4D297EQ36445103-468F0627-2E10-49E1-9FC3-B3A086CCA94BQ36496583-FC1FF235-46C8-456B-A182-FD0701A0E0E8Q36826423-DDD5D7CA-378F-4C4F-8922-754CDF2820B4Q37195641-283D1375-E4EA-4FF1-9B68-D78F5C73168BQ37648725-AA81C01E-723C-4C15-8C5A-023FF90CE80AQ37977983-5CA613F5-867D-41CE-BAE6-5531B398B48EQ37980883-427BEDD2-9534-418F-93AC-DF0075CDEC0EQ38008458-0967F5CC-1F7A-48B4-8A6C-E737D3075B74Q38332341-A399FC16-CB40-445A-86B2-6CA90EF4BA0FQ39369560-F997BB5B-2605-49F0-B426-6C1C54F22306Q40524166-FC4339C8-EECF-4F5B-B516-C082F47C6FCAQ41386398-6984A275-0A1D-4745-8B09-33DEC69B3F1CQ41825525-C3127980-F93B-4B4A-A016-AC57064225AAQ41991036-A5CDB357-C26C-49A4-A078-75ADE8D107E4Q42130161-747E4DD2-A816-40E4-BAA9-9D3899FC129FQ42319646-E8D1C340-9D2E-401C-B674-380EE834B3E3Q46603356-02A7A4E2-A6E8-42CB-846E-3A39B43892DAQ46670784-FBD9210B-1396-4FEC-9E12-A034DFEE3B3CQ48163282-7EC25C11-B9B6-423A-9ABB-CEA6591CEF4DQ49142892-16D88D11-39F1-4CAF-A7ED-4EB558FE0372Q51253744-7F3749AC-E17A-4962-AB72-3FA2F727A396Q54337323-0D17320C-F9F8-4BB5-9C83-F7C76B3857F5
P2860
Defined anaerobic growth medium for studying Candida albicans basic biology and resistance to eight antifungal drugs.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Defined anaerobic growth mediu ...... nce to eight antifungal drugs.
@ast
Defined anaerobic growth mediu ...... nce to eight antifungal drugs.
@en
type
label
Defined anaerobic growth mediu ...... nce to eight antifungal drugs.
@ast
Defined anaerobic growth mediu ...... nce to eight antifungal drugs.
@en
prefLabel
Defined anaerobic growth mediu ...... nce to eight antifungal drugs.
@ast
Defined anaerobic growth mediu ...... nce to eight antifungal drugs.
@en
P2093
P2860
P1476
Defined anaerobic growth mediu ...... nce to eight antifungal drugs.
@en
P2093
Jacob M Hornby
Kenneth W Nickerson
Raluca Dumitru
P2860
P304
P356
10.1128/AAC.48.7.2350-2354.2004
P407
P577
2004-07-01T00:00:00Z